Arbutus’ CSO, Dr. Michael J Sofia, awarded Lasker-DeBakey Clinical Medical Research Award
On Sept. 13, 2016, Arbutus Biopharma announced that Dr. Michael J. Sofia, Arbutus’ Chief Scientific Officer, had been…
-
-
Seqirus received FDA approval for AFLURIA® QUADRIVALENT (Influenza Vaccine) for people 18 years of age and older
On Aug. 29, 2016, Seqirus announced that the U.S. Food and Drug Administration (FDA) had approved AFLURIA® QUADRIVALENT…
-
AAP released new policy statement that urged states to eliminate all non-medical exemptions to vaccine requirements
On Aug. 29, 2016, the American Academy of Pediatrics (AAP) released new policy statement that urged states to…
-
CDC published 2016-17 influenza vaccination recommendations
On Aug. 26, 2016, the U.S. Centers for Disease Control and Prevention (CDC) published 2016-17 influenza vaccination recommendations….
-
Siteman Cancer Center received a $10.4 million grant from the NCI
On Aug. 15, 2016, Siteman Cancer Center received a $10.4 million five-year grant to Washington University researchers and…
-
FDA extended the age indication for PCV13 (Prevnar 13) to include adults age 18 through 49 years
On Jul. 12, 2016, Pfizer announced that Prevnar 13 (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein]) received U.S….
-
ACIP voted that live attenuated influenza vaccine (LAIV) should not be used during the 2016-2017 flu season
On Jun. 22, 2016, the U.S. Centers for Disease Control and Prevention’s (CDC) Immunization Practices Advisory Committee (ACIP)…
-
Biotechnology | FDA | Vaccine
FDA approved Vaxchora for the prevention of cholera
On Jun. 12, 2016, the U.S. Food and Drug Administration (FDA) approved Vaxchora, a vaccine for the prevention…
-
Agriculture | Biotechnology | Infectious Disease | Medicine | Pharmaceutical | Therapeutics | Vaccine
Texas A&M and iBio execute development agreement for plant-produced pharmaceuticals
On Jun. 7, 2016, the Texas A&M University System (TAMUS) announced it had entered into a joint development…
-
TEC Edmonton broke ground on newest technology accelerator with Merck Canada
On Sept. 5, 2017, business incubator TEC Edmonton announced a strategic partnership with Merck Canada to provide new…
-
Bioject Medical Technologies was acquired by Inovio Pharmaceuticals
On Mar. 14, 2016, Inovio Pharmaceuticals announced an agreement to acquire all of Bioject Medical Technologies’ assets including…
-
MD Anderson received $14 million in CPRIT research funding to recruit top talent
On Feb. 17, 2016, MD Anderson Cancer Center was awarded $14 million from the Cancer Prevention and Research…
-
Artificial Intelligence | Biotechnology | CRISPR | Genomics | Medicine | NIH | Non-Profit Research | Oncology | Therapeutics | Vaccine
The Cancer MoonShot Project was announced
On Jan. 12, 2016, a consortium of industry, government, and academia announced the launch of the Cancer MoonShot…
-
FDA approved new injectable influenza vaccine, Fluad, for use in people age 65 years and older
On Nov. 25, 2015, Seqirus announced that the U.S. Food and Drug Administration (FDA) had approved Fluad™ (Influenza…
-
ACIP published recommendations for the use of serogroup B meningococcal vaccines in adolescents and young adults
On Oct. 23, 2015, the Immunization Practices Advisory Committee (ACIP) published recommendations for the use of serogroup B…
-
VGTI Florida turned over remaining assets to creditors: the City of Port St Lucie and the State of Florida
On Oct. 1, 2015, the Vaccine & Gene Therapy Institute of Florida (VGTI Florida) announced plans to turn…
-
Biotechnology | CDC | FDA | NIH | Non-Profit Research | Pharmaceutical | Vaccine
CDC published updated ACIP recommendations regarding the intervals between PCV13 and PPSV23 vaccines
On Sept. 4, 2015, the U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices…
-
ACIP published recommendations for yellow fever booster doses
On Jun. 19, 2015, the Immunization Practices Advisory Committee (ACIP) published recommendations for yellow fever booster doses. Yellow…
-
ACIP published recommendations for use of serogroup B meningococcal vaccines in people age ten years and older at increased risk
On Jun. 12, 2015, the Advisory Committee on Immunization Practices (ACIP) recommended that adolescents and young adults aged…
-
American Medical Association adopted policy ﾠthat supported ending non-medical vaccine exemptions
On Jun. 8, 2015, the American Medical Association adopted a new policyﾠthat recommended that states have in place…
-
Biotechnology | CRO | HIV | Infectious Disease | NIH | Non-Profit Research | Vaccine | Veterinary
The New England Primate Research Center closed its doors
On May 31, 2015, the New England Primate Research Center (NEPRC) announced that it intended to wind down…
-
Zika virus circulation was confirmed in Brazil
On May 15, 2015, Zika virus circulation was confirmed in Brazil, and the Centers for Disease Control and…
-
Biotechnology | Infectious Disease | Measles | Polio | Vaccine | WHO | Women's Health
Pan American Health Organization declared Rubella Eliminated in the Americas
On Apr. 29, 2015, the Pan American Health Organization ﾠdeclared that the Americas region has become the first…
-
CDC published ACIP recommendations for use of 9-valent HPV vaccine
On Mar. 27, 2015, the U.S. Centers for Disease Control and Prevention (CDC) recommended 9-valent human papillomavirus (HPV)…
-
CDC published ACIP recommendations for typhoid vaccination
On Mar. 27, 2015, the U.S. Centers for Disease Control and Prevention (CDC) published new Immunization Practices Advisory…
-
Biotechnology | FDA | Vaccine
FDA approved the Quadracelﾠ DTaP+IPV ﾠvaccine for use in children age 4-6 years
On Mar. 24, 2015, the U.S. Food and Drug Administration (FDA) licensed an additional combined diphtheria and tetanus toxoids…
-
The Human Vaccines Project was launched
On Feb. 17, 2015, the International AIDS Vaccine Initiative (IAVI) announced it had received a grant of US…
-
Biotechnology | CDC | Diagnostics | Infectious Disease | Measles | Vaccine
CDC’s Health Alert Network issued health advisory about multi-state outbreak of measles linked to Disneyland
On Jan. 23, 2015, the U.S. Centers for Disease Control and Prevention (CDC) Health Alert Network issued a…
-
FDA approved the use of Bexsero, the second vaccine licensed in the U.S. to prevent serogroup B meningococcal disease
On Jan. 23, 2015, Novartis announced the US Food and Drug Administration (FDA) had granted accelerated approval of…
-
Biotechnology | CDC | Diagnostics | Infectious Disease | Medicine | NIH | Therapeutics | Vaccine | WHO
The CDC responded to the West Africa Ebola outbreak
On Feb. 27, 2015, the U.S. Centers for Disease Control and Prevention (CDC) responded to the West Africa…
